(Q33646478)

28 July 2017

title

Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression (English)

1 reference

28 July 2017

1 reference

1 reference

G L Daikos

1

1 reference

28 July 2017

J Pulido

series ordinal

2

1 reference

28 July 2017

S B Kathpalia

series ordinal

3

1 reference

28 July 2017

G G Jackson

series ordinal

4

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

British Journal of Ophthalmology

28 July 2017

published in

1 reference

28 July 2017

volume

72

1 reference

28 July 2017

issue

7

1 reference

28 July 2017

page(s)

521-524

1 reference

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041517

Intraocular 9-([2-hydroxy-1-(hydroxymethyl) ethoxy] methyl) guanine levels after intravitreal and subconjunctival administration

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041517

Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041517

Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041517

Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041517

Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside

30 October 2018

1 reference

12 December 2020

Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

1 reference

12 December 2020

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease

1 reference

12 December 2020

Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agent

1 reference

12 December 2020

Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine

1 reference

12 December 2020

BW B759U for cytomegalovirus retinitis: intraocular drug penetration

1 reference

12 December 2020

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

12 December 2020

9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.72.7.521

1 reference

28 July 2017

1 reference

28 July 2017

1 reference